Ms. Kadala is an experienced executive in the medical device and electronics industries, with a background in electrical engineering as well as intellectual property law. Most recently, she was CEO and general counsel of InGeneron since 2011. During her tenure, the valuation of the company increased substantially. Effecting such an increase in valuation required successfully balancing and integrating academic and commercial medicine to commercialize research for the marketplace. InGeneron is a biotechnology regenerative cell "start up" that results from cooperation with institutions such as U.T. Health Science Center at M.D. Anderson and Tulane University, commercial entities, non-profits, and private researchers. At InGeneron, she contributed to the product development; was an inventor on a key patent protecting our intellectual property; and developed the global patent strategy. She also generated the regulatory strategy, and navigated the regulatory roadmap to approval in Europe and the US for medical and veterinary use. She oversaw the introduction of our product to the veterinary and medical markets. Because the company was small, she actively participated in academic, regulatory and business roles at InGeneron. To fuel the fire she raised money through SBIR grants and investor presentations. She added more value by negotiating contracts with major medical device and pharma companies, as well as by leveraging relationships with foundations and academic institutions. Her legal expertise was critical in managing InGeneron’s patent portfolio to maximize value, and to guide the company in its interactions with regulatory bodies in the United States and in the E.U., As CEO, she oversaw the accounting, marketing and sales functions of the company. As the face of the company, she gained extensive experience in formulating presentations to academic, regulatory, and professional organizations for the purposes of gaining the trust and partnership of the scientific and medical communities and regulatory bodies.
Patent Evaluation and Litigation.
Prior to InGeneron, Ms. Kadala was a partner at prominent national law firms, Weil, Gotshal & Manges and Fish & Richardson, specializing in intellectual property. She obtained patents and established trade secret protections for a diverse range of inventions in medical technology and electronics. She appraised the strength of external intellectual property and in some cases, licensed technology that strengthened the clients IP position. She gained tremendous insight into the tactics and strategies required to effectively establish and enforcing intellectual property rights through 20 years of past experience as a litigation and licensing attorney in national intellectual property law firms. She has extensive experience and success in litigating medical device patents and technology against major medical device companies, including roles as one of the key intellectual property attorneys in several successful cases against Boston Scientific, Medtronic and others that netted her client well over $75 million.
She is also an inventor on a pending patent application – an experience that provides unique insight as she has now participated in the patenting process from the perspective of an inventor as well as the attorney responsible for prosecuting, enforcing and/or licensing and commercializing inventions.
Finally, long before the terms ‘venture philanthropy’ and ‘social enterprise’ became popular, Ms. Kadala was involved with entrepreneurial approaches to fundraising and project development for charitable organizations, a way to use her expertise to give back to the community.